Skip to main content

Colorectal Cancer

Explore Hightower’s impactful studies that have reshaped colorectal cancer management strategies.


About Colorectal Cancer Study & Trials

Colorectal cancer is the second most common cancer diagnosed in the United States, affecting millions of people annually. It arises in the colon or rectum, often starting as polyps that can develop into cancerous tumors. Symptoms may include rectal bleeding, blood in stool, persistent abdominal pain, and changes in bowel habits.

At Hightower, we do clinical trials for colorectal cancer, investigating promising new medications, targeted therapies, and minimally invasive surgical techniques. These trials offer patients access to innovative treatments that might not yet be widely available.

Current Status

Not Recruiting

Study Count


Frequently Asked Questions

What is a colorectal cancer clinical trial?

A colorectal cancer clinical trial is a research study designed to investigate new treatments, screening methods, prevention strategies, or supportive care options for individuals affected by colorectal cancer.

Who is eligible to participate in a colorectal cancer clinical trial?

Eligibility criteria for colorectal cancer clinical trials typically include individuals diagnosed with colorectal cancer at various stages, as well as those at increased risk of developing the disease due to family history or genetic predisposition.

What are the potential benefits of participating in a colorectal cancer clinical trial?

Participation in a colorectal cancer clinical trial may offer access to novel treatments or interventions unavailable outside the trial setting.